These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14413273)

  • 1. Antigenic modulation of Bordetella pertussis.
    LACEY BW
    J Hyg (Lond); 1960 Mar; 58(1):57-93. PubMed ID: 14413273
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic modulation of Haemophilus pertussis.
    LACEY BW
    J Gen Microbiol; 1951 Aug; 5(3):xxi. PubMed ID: 14873915
    [No Abstract]   [Full Text] [Related]  

  • 3. A versatile, non genetically modified organism (GMO)-based strategy for controlling low-producer mutants in Bordetella pertussis cultures using antigenic modulation.
    Goffin P; Slock T; Smessaert V; De Rop P; Dehottay P
    Biotechnol J; 2015 Aug; 10(8):1269-80. PubMed ID: 26014907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional patterns of antigenic modulation of Haemophilus pertussis, H. parapertussis and H. bronchisepticus.
    LACEY BW
    J Gen Microbiol; 1953 Feb; 8(1):iii-iv. PubMed ID: 13035053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contributions to the study of antigenic relationships of Bordetella pertussis with Bordetella parapertussis].
    Barber C; Soare I; Dumitresco M
    Arch Roum Pathol Exp Microbiol; 1964 Mar; 23(1):115-22. PubMed ID: 4290794
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of the ventral posterior hypothalamus on Bordetella pertussis vaccine-induced eosinophilia.
    TJABBES T; de WIED
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():218-22. PubMed ID: 13921428
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antigenic and immunogenic qualities of various phases of Hemophilus pertussis].
    MAMAEVA EA
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Apr; 27(4):13-7. PubMed ID: 13338793
    [No Abstract]   [Full Text] [Related]  

  • 8. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Note on a hemosensitizing antigen isolated from Bordetella pertussis].
    BARBER C; SOARE I; WEINBACH R
    Rev Sci Med; 1961; 6():7-12. PubMed ID: 13864828
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antigenic structure of the English national and American strains of phase I Hemophilus pertussis].
    MARGNI RA
    Prensa Med Argent; 1956 Mar; 43(9):764-5. PubMed ID: 13350008
    [No Abstract]   [Full Text] [Related]  

  • 11. Cloning of Bordetella pertussis outer membrane proteins in Escherichia coli.
    Shareck F; Cameron J
    Dev Biol Stand; 1985; 61():273-80. PubMed ID: 2872114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of the anaphylaxis enhancing and adjuvant effects of Bordetella pertussis by a prior injection of B. pertussis.
    KIND LS; ROFFLER SK
    J Immunol; 1961 Mar; 86():324-30. PubMed ID: 13756040
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigens of Bordetella pertussis. I. Activities of cell walls and protoplasm.
    MUNOZ J; RIBI E; LARSON CL
    J Immunol; 1959 Nov; 83():496-501. PubMed ID: 14425265
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between growth rate and loss of histamine-sensitizing factor during antigenic modulation in Bordetella pertussis.
    Idigbe EO
    Microbios; 1987; 49(199):79-89. PubMed ID: 2883559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis in Bordetella pertussis-treated mice. III. Passive cutaneous anaphylaxis.
    MUNOZ J; ANACKER RL
    J Immunol; 1959 Dec; 83():640-4. PubMed ID: 14425264
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the prevention of sensitization by Bordetella pertussis in alloxan diabetic mice.
    GANLEY OH
    Can J Biochem Physiol; 1962 Sep; 40():1179-83. PubMed ID: 13896653
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan.
    Han HJ; Kamachi K; Okada K; Toyoizumi-Ajisaka H; Sasaki Y; Arakawa Y
    Vaccine; 2008 Mar; 26(12):1530-4. PubMed ID: 18291563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of synthetic peptides to map antigenic sites of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Abens J; Undén A; Bartfai T
    J Infect Dis; 1988 Apr; 157(4):738-42. PubMed ID: 2450153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative studies in diphtheria prophylaxis. Antigenic interactions. I. Simultaneous inoculations.
    BARNES JM; HOLT LB
    Br J Exp Pathol; 1955 Aug; 36(4):415-24. PubMed ID: 13250118
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaphylaxis in Bordetella pertussis-treated mice. II. Passive anaphylaxis with homologous antibody.
    MUNOZ J; ANACKER RL
    J Immunol; 1959 Nov; 83():502-6. PubMed ID: 14425263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.